| Richard F Garrett Trauma Solutions Llc | |
|
2925 Ledo Rd Ste 1 Albany GA 31707-1267 | |
| (229) 483-5050 | |
| Not Available |
| Full Name | Richard F Garrett Trauma Solutions Llc |
|---|---|
| Speciality | Social Worker |
| Location | 2925 Ledo Rd Ste 1, Albany, Georgia |
| Authorized Official Name and Position | Richard F Garrett (OWNER) |
| Authorized Official Contact | 2294835050 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Richard F Garrett Trauma Solutions Llc 2950 Ledo Road Ste 1 Albany GA 31707-1265 Ph: (229) 483-5050 | Richard F Garrett Trauma Solutions Llc 2925 Ledo Rd Ste 1 Albany GA 31707-1267 Ph: (229) 483-5050 |
| NPI Number | 1790229805 |
|---|---|
| Provider Enumeration Date | 12/08/2016 |
| Last Update Date | 03/15/2023 |
| Certification Date | 03/13/2023 |
| Medicare PECOS PAC ID | 4183907629 |
|---|---|
| Medicare Enrollment ID | O20170208001151 |
News Archive
The House GOP moved forward Thursday with targeted measures to advance their own version of health legislation. Four committee chairmen outlined plans to develop specific plans to kill or replace certain elements of the health law. A bill to permit interstate sales of health insurance is among the specific proposals on the table, and a group of conservative Republicans also unveiled a fiscal plan that would stall health law implementation efforts by defunding them.
The Multiple Sclerosis Foundation will officially launch their "Orange 4 MSF" campaign on Monday, February 16th to promote MS awareness. Since orange is the official color of awareness, MSF would like the public to show their support by taking a selfie with an orange and then posting it on social media with #orange4msf.
Obesity almost always increases cancer risk and worsens outcomes, but researchers led by scientists at Dana-Farber Cancer Institute report that overweight patients with advanced kidney cancer had significantly longer survival than those who were normal or underweight.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-PCS, an RNAi therapeutic targeting proprotein convertase subtilisin/kexin type 9, or PCSK9, for the treatment of severe hypercholesterolemia.
ImmunoCellular Therapeutics, a biotechnology company focused on the development of novel immune-based cancer therapies, today announced long-term data from a Phase I clinical trial of ICT-107, the Company's lead cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790229805 | NPI | - | NPPES |
| Provider Name | Richard Francis Garrett |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1942393962 PECOS PAC ID: 5092098533 Enrollment ID: I20170208001190 |
News Archive
The House GOP moved forward Thursday with targeted measures to advance their own version of health legislation. Four committee chairmen outlined plans to develop specific plans to kill or replace certain elements of the health law. A bill to permit interstate sales of health insurance is among the specific proposals on the table, and a group of conservative Republicans also unveiled a fiscal plan that would stall health law implementation efforts by defunding them.
The Multiple Sclerosis Foundation will officially launch their "Orange 4 MSF" campaign on Monday, February 16th to promote MS awareness. Since orange is the official color of awareness, MSF would like the public to show their support by taking a selfie with an orange and then posting it on social media with #orange4msf.
Obesity almost always increases cancer risk and worsens outcomes, but researchers led by scientists at Dana-Farber Cancer Institute report that overweight patients with advanced kidney cancer had significantly longer survival than those who were normal or underweight.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-PCS, an RNAi therapeutic targeting proprotein convertase subtilisin/kexin type 9, or PCSK9, for the treatment of severe hypercholesterolemia.
ImmunoCellular Therapeutics, a biotechnology company focused on the development of novel immune-based cancer therapies, today announced long-term data from a Phase I clinical trial of ICT-107, the Company's lead cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.
› Verified 7 days ago
News Archive
The House GOP moved forward Thursday with targeted measures to advance their own version of health legislation. Four committee chairmen outlined plans to develop specific plans to kill or replace certain elements of the health law. A bill to permit interstate sales of health insurance is among the specific proposals on the table, and a group of conservative Republicans also unveiled a fiscal plan that would stall health law implementation efforts by defunding them.
The Multiple Sclerosis Foundation will officially launch their "Orange 4 MSF" campaign on Monday, February 16th to promote MS awareness. Since orange is the official color of awareness, MSF would like the public to show their support by taking a selfie with an orange and then posting it on social media with #orange4msf.
Obesity almost always increases cancer risk and worsens outcomes, but researchers led by scientists at Dana-Farber Cancer Institute report that overweight patients with advanced kidney cancer had significantly longer survival than those who were normal or underweight.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that it has initiated dosing in its Phase I clinical trial with ALN-PCS, an RNAi therapeutic targeting proprotein convertase subtilisin/kexin type 9, or PCSK9, for the treatment of severe hypercholesterolemia.
ImmunoCellular Therapeutics, a biotechnology company focused on the development of novel immune-based cancer therapies, today announced long-term data from a Phase I clinical trial of ICT-107, the Company's lead cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer.
› Verified 7 days ago
Bailey Healthcare Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2416 Suite B Westgate Dr, Albany, GA 31707 Phone: 229-881-0533 Fax: 888-273-6926 | |
Southwest Georgia Neurology, P.c. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2709 Meredyth Dr, Suite 230, Albany, GA 31707 Phone: 229-438-0703 Fax: 229-883-0701 | |
Journey Counseling And Psyhological Services, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2339 Lake Park Dr, Albany, GA 31707 Phone: 229-255-3099 Fax: 229-638-6302 | |
Magnolia Medical Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 701 14th Avenue, Albany, GA 31701 Phone: 229-446-9477 Fax: 229-446-9422 | |
The Renaissance Centre, Inc. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 506 N Jackson St, Albany, GA 31701 Phone: 229-889-7200 Fax: 229-889-7393 | |
Ann Priddy Lcsw Pc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1511 W 3rd Ave, Suite 104, Albany, GA 31707 Phone: 229-483-5050 Fax: 229-485-1103 | |
A New Normal Behavioral Wellness Solutions Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1142 Dawson Rd Ste 103, Albany, GA 31707 Phone: 229-349-3728 |